Estadísticas
Total de Visitas
| Visitas | |
|---|---|
| Sunitinib-containing carborane pharmacophore with the ability to inhibit tyrosine kinases receptors FLT3, KIT and PDGFR-β, exhibits powerful in vivo anti-glioblastoma activity | 100 |
Total de Visitas por Mes
| julio 2025 | agosto 2025 | septiembre 2025 | octubre 2025 | noviembre 2025 | diciembre 2025 | enero 2026 | |
|---|---|---|---|---|---|---|---|
| Sunitinib-containing carborane pharmacophore with the ability to inhibit tyrosine kinases receptors FLT3, KIT and PDGFR-β, exhibits powerful in vivo anti-glioblastoma activity | 3 | 4 | 4 | 13 | 9 | 8 | 9 |
Total de Descargas
| Visitas | |
|---|---|
| 10.3390cancers12113423.pdf | 61 |
Top Países
| Visitas | |
|---|---|
| Estados Unidos | 31 |
| China | 13 |
| Canadá | 11 |
| Uruguay | 9 |
| Brasil | 5 |
| Vietnam | 5 |
| Irlanda | 3 |
| Argentina | 2 |
| Japón | 2 |
| Rusia | 2 |
Top Ciudades
| Visitas | |
|---|---|
| Ottawa | 10 |
| Montevideo | 9 |
| Fairfield | 8 |
| Hanoi | 5 |
| Beijing | 3 |
| Dublin | 3 |
| Menlo Park | 3 |
| Oakland | 3 |
| Redmond | 3 |
| Ashburn | 2 |